Development and full validation of an UPLC-MS/MS method for the determination of an anti-allergic indolinone derivative in rat plasma, and application to a preliminary pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 902, Issue , 2012, Pages 27-34

  Oufir, Mouhssin ^a   Sampath, Chethan ^b   Butterweck, Veronika ^b,c   Hamburger, Matthias ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

Anti allergic; Indolinone; Isatis tinctoria L.; Pharmacokinetic study; UPLC MS MS; Validation

Indexed keywords

ANTI-ALLERGIC; INDOLINONE; PHARMACOKINETIC STUDIES; TINCTORIA; UPLC-MS/MS; VALIDATION;

LITHIUM; PHARMACOKINETICS;

BODY FLUIDS;

3 (4 HYDROXY 3,5 DIMETHOXYBENZYLIDENE)INDOLIN 2 ONE; INDOLE DERIVATIVE; LITHIUM; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); EXTRACTION; FREEZE THAWING; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; RELIABILITY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

ANIMALS; ANTI-ALLERGIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; INDOLES; ISOMERISM; LIMIT OF DETECTION; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

ISATIS TINCTORIA; RATTUS;

EID: 84864077149     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.06.009     Document Type: Article

References (21)

1. Wu X., Liu Y., Sheng W., Sun J., Qin G. Chemical constituents of Isatis indigotica. Planta Med. 1997, 63:55.
2. Ruester G.U., Hoffmann B., Hamburger M. Pharmazie 2004, 59:236.
3. Mohn T., Plitzko I., Hamburger M. Phytochemistry 2009, 70:924.
4. Hamburger M. Phytochem. Rev. 2002, 1:333.
5. Danz H., Stoyanova S., Wippich P., Brattström A., Hamburger M. Planta Med. 2001, 67:411-416.
6. Danz H., Stoyanova S., Thomet O.A.M., Simon H.U., Dannhardt G., Ulbrich H., Hamburger M. Planta Med. 2002, 68:875-880.
7. Ishihara T., Kohno K., Ushio S., Iwaki K., Ikeda M., Kurimoto M. Eur. J. Pharmacol. 2000, 407:197-204.
8. Pergola C., Jazzar B., Rossi A., Northoff N., Hamburger M., Sautebin L., Werz O. Brit. J. Pharmacol. 2012, 165:765-776.
9. Hoessel R., Leclerc S., Endicott J.A., Nobel M.E., Lawrie A., Tunnah P., Leost M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., Meijer L. Nat. Cell Biol. 1999, 1:60.
10. Kunikata T., Tatefuji T., Aga H., Iwaki K., Ikeda M., Kurimoto M. Eur. J. Pharmacol. 2000, 410:93-100.
11. Kiefer S., Mertz A.C., Koryakina A., Hamburger M., Kueenzi P. Eur. J. Pharm. Sci. 2010, 40:143.
12. Lipinski C.A., Lombardo F., Daminy B.W., Feeney P.J. Adv. Drug. Deliv. Res. 2001, 46:3-26.
13. Mohn T., Potterat O., Hamburger M. Planta Med. 2007, 73:151.
14. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., Weiner R. AAPS J. 2007, 9:30.
15. US Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Guidance for Industry: Bioanalytical Method Validation, May 2001.
16. Sun L., Tran N., Tang F., App H., Hirth P., McMahon G., Tang C. J. Med. Chem. 1998, 41:2588.
17. Almeida A.M., Castel-Branco M.M., Falcao A.C. J. Chromatogr. B 2002, 774:215.
18. Miller J.C., Miller J.N. Statistics for Analytical Chemistry 1984, John Wiley & Sons, Hoboken, New Jersey, p. 107.
19. Neervannan S. Expert Opin. Drug Metab. Toxicol. 2005, 2:715.
20. Vessman J., Stefan R.I., Van Staden J., Danzer K., Linder W., Burns D.T., Fajgelj A., Muller H. Pure Appl. Chem. 2001, 73:1381.
21. Aboul-Enein H.Y. Accred. Qual. Assur. 2000, 5:180.